インスリンポンプの米国市場:市場規模・シェア・分析・成長性・需要予測

調査会社DPI Research社が発行したリサーチレポート(データ管理コード:DATA7100534)
◆英語タイトル:United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022
◆発行会社/調査会社:DPI Research
◆商品コード:DATA7100534
◆発行日:2017年7月10日
◆調査対象地域:米国
◆産業分野:医療
◆ページ数:145
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,350 ⇒換算¥152,550見積依頼/購入/質問フォーム
Site LicenseUSD1,850 ⇒換算¥209,050見積依頼/購入/質問フォーム
EnterprisewideUSD1,850 ⇒換算¥209,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DPI Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[インスリンポンプの米国市場:市場規模・シェア・分析・成長性・需要予測]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

United States Insulin Pump Market is expected to reach US$ 3.8 Billion by the year end of 2022.

Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.

This is the 2nd latest edition report published by the Market Report Publisher. “United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” provides a deep and thorough evaluation of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• United States Insulin Pump Market: Reimbursement & Regulation System
• United States Insulin Pump Market – Major Deal Types
• Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Insulin Pump Market

Key Companies Covered in the Report are as follows:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation and
• Tandem Diabetes Care

*** レポート目次(コンテンツ)***

Table of Contents

1. Executive Summary

2. United States Diabetes Population (2011 – 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes

3. United States Insulin Pump Market Analysis (2011– 2022)
3.1 Insulin Pump Users
3.1.1 Type 1 Diabetes Insulin Pump Users
3.1.2 Type 2 Diabetes Insulin Pump Users
3.2 Insulin Pump Market

4. Key Drivers and Inhibitors of the United States Insulin Pump Market
4.1 Market Drivers
4.2 Inhibitors

5. United States Insulin Pump Preferred Brand – By Product
5.1 Pediatric
5.2 Adult

6. United States Insulin Pump Market: Reimbursement & Regulation System
6.1 Reimbursement System
6.2 Regulation System

7. United States Insulin Pump Market – Major Deal Types
7.1 Insulin Pump Market – Collaboration Deals
7.2 Insulin Pump Market – Licensing Agreement
7.3 Insulin Pump Market – Exclusive Agreement
7.4 Insulin Pump Market – Partnerships Deals

8. Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
8.1 Year 2016
8.2 Year 2015
8.3 Year 2014
8.4 Year 2013
8.5 Year 2012

9. Key Companies Analysis
9.1 Medtronic
9.1.1 Business Overview
9.1.2 Insulin Pump – Product Details
9.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.1.4 Insulin Pump – Latest Development & Trends
9.2 Tandem Diabetes Care
9.2.1 Business Overview
9.2.2 Insulin Pump – Product Details
9.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022)
9.2.4 Insulin Pump – Latest Development & Trends
9.3 Insulet Corporation
9.3.1 Business Overview
9.3.2 Insulin Pump – Product Details
9.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022)
9.3.4 Insulin Pump – Latest Development & Trends
9.4 Animas Corporation (Johnson & Johnson)
9.4.1 Business Overview
9.4.2 Insulin Pump – Product Details
9.4.3 Johnson & Johnson – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.4.4 Insulin Pump – Latest Development & Trends
9.5 Roche
9.5.1 Business Overview
9.5.2 Insulin Pump – Product Details
9.5.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022)
9.5.4 Insulin Pump – Latest Development & Trends

List of Tables

Table 4 1: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
Table 7 1: Collaboration Deals in Insulin Pump Market, 2009 – 2016
Table 7 2: Licensing Agreement in Insulin Pump Market, 2015 – 2016
Table 7 3: Exclusive Agreement in Insulin Pump Market, 2011 – 2017
Table 7 4: Partnerships Deals in Insulin Pump Market, 2010 – 2017




List of Figures

Figure 2 1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2 2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2 3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2 4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2 5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2 6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2 7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2 8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 3 1: United States – Insulin Pump Users (Number), 2011 – 2016
Figure 3 2: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 3 3: United States – Type 1 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3 4: United States – Forecast for Type 1 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3 5: United States – Type 2 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3 6: United States – Forecast for Type 2 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3 7: United States – Insulin Pump Market (Million US$), 2011 – 2016
Figure 3 8: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 5 1: United States – Pediatric Insulin Pump Preference by Product(Percent),2016
Figure 5 2: United States – Adult Insulin Pump Preference by Product(Percent),2016
Figure 9 1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9 2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9 3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
Figure 9 4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9 5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
Figure 9 6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9 7: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9 8: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9 9: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
Figure 9 10: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022




*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DATA7100534 )"インスリンポンプの米国市場:市場規模・シェア・分析・成長性・需要予測" (英文:United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022)はDPI Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。